Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice

Parasitology Research

Volumn 112, Issue 3, 2013, Pages 1313-1321

  Jacob, P L ^a   Leite, J A ^a   Alves, A K A ^a   Rodrigues, Y K S ^a   Amorim, F M ^a   Neris P L N ^a   Oliveira, M R ^a   Rodrigues Mascarenhas, S ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; OUABAIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; FEMALE; IMMUNOMODULATION; LEISHMANIASIS; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM MACROPHAGE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIASIS; MICE; NEUTROPHILS; OUABAIN; TUMOR NECROSIS FACTOR-ALPHA;

LEISHMANIA AMAZONENSIS; MURINAE; MUS; STROPHANTHUS GRATUS;

EID: 84878422619     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-012-3146-9     Document Type: Article

References (40)

1. Abdul KM, Ramchender RP (1995) Modulatory effect of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) on macrophage functions in BALB/c mice. I. Potentiation of macrophage bactericidal activity. Immunopharmacology 30(3):231-236
2. Barral A, Pedral-Sampaio D, Grimaldi Júnior G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaro R, Barral-Netto M, Carvalho EM, Johnson WD (1991) Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44(5):536-546
3. Bates PA (2007) Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasit 37(10):1097-1106. doi: 10.1016/j.ijpara.2007.04.003
4. Bauer N, Müller-Ehmsen J, Krämer U, Hambarchian N, Zobel C, Schwinger RH, Neu H, Kirch U, Grünbaum EG, Schoner W (2005) Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β-blockade and angiotensin-converting enzyme inhibition. Hypertension 45(5):1024-1028. doi: 10.1161/01.HYP.0000165024.47728.f7
5. 2+ stores and cell responsiveness. Am J Physiol 264(6 Pt 1):C1367-C1387
6. Blaustein MP, Zhang J, Chen L, Song H, Raina H, Kinsey SP, Izuka M, Iwamoto T, Kotlikoff MI, Lingrel JB, Philipson KD, Wier WG, Hamlyn JM (2009) The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 53(2):291-298. doi: 10.1161/HYP.108.119974
7. Dantas-Torres F (2006) Do any insects other than phlebotomine sandflies (Diptera: Psychodidae) transmit Leishmania infantum (Kinetoplastida: Trypanosomatidae) from dog to dog? Vet Parasitol 136(3-4):379-380. doi: 10.1016/j.vetpar.2005.12.010
8. De Moraes VL, Olej B, de la Rocque L, Rumjanek VM (1989) Lack of sensitivity to ouabain in natural killer activity. FASEB J 3(12):2425-2429
9. De Oliveira MR, Tafuri WL, Nicoli JR, Vieira EC, Melo MN, Vieira LQ (1999) Influence of microbiota in experimental cutaneous Leishmaniasis in Swiss mice. Rev Inst Med Trop Sao Paulo 41(2):87-94
10. De Souza Carmo EV, Katz S, Barbieri CL (2010) Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages. PLoS One 5(11):e13815. doi: 10.1371/journal.pone.0013815
11. De Vasconcelos DIB, Leite JA, Carneiro LT, Piuvezam MR, De Lima MRV, De morais LCL, Rumjanek VM, Rodrigues-Mascarenhas S (2011) Anti-inflammatory and antinociceptive activity of ouabain in mice. Mediat Inflamm 2011:912925. doi: 10.1155/2011/912925
12. 2+ pools. Hypertension 41(6):1386-1392. doi: 10.1161/01.HYP.0000072801.90600.C2
13. Ferrandi M, Manunta P, Balzan S, Hamlyn JM, Bianchi G, Ferrari P (1997) Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 30(4):886-896
14. Fimbel SM, Montgomery JE, Burket CT, Hyde DR (2007) Regeneration of inner retinal neurons after intravitreal injection of ouabain in zebrafish. J Neurosci 27(7):1712-1724. doi: 10.1523/JNEUROSCI.5317-06.2007
15. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T (1992) Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 44(3):377-399
16. Goto A, Yamada K, Nagoshi H, Terano Y, Omata M (1995) Stress-induced elevation of ouabainlike compound in rat plasma and adrenal. Hypertension 26(6):1173-1176. doi: 10.1161/01.HYP.26.6.1173
17. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM (1992) Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86(2):420-425
18. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH (1991) Identification and characterization of a ouabain-like compound from human plasma. PNAS 88(14):6259-6263
19. Jorens PG, Matthys KE, Bult H (1995) Modulation of nitric oxide synthase activity in macrophages. Mediat Inflamm 4(2):75-89. doi: 10.1155/ S0962935195000135
20. Kavoosi G, Ardestani SK, Kariminia A, Zeinali M, Alimohammadian MH (2008) Leishmania major: effects of proteophosphoglycan on reactive oxygen species, IL-12, IFN-gamma and IL-10 production in healthy individuals. Exp Parasitol 120(1):62-66. doi: 10.1016/j.exppara.2008.04.022
21. Kobets T, Grekov I, Lipoldova M (2012) Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem 19(10):1443-1474
22. Laredo J, Hamilton BP, Hamlyn JM (1994) Ouabain is secreted by bovine adrenocortical cells. Endocrinology 135(2):794-797
23. Locksley RM, Scott P (1991) Helper T-cell subsets in mouse Leishmaniasis: induction, expansion and effector function. Immunol Today 12(3):A58-A61. doi: 10.1016/S0167-5699(05)80017-9
24. Mann CL, Bortner CD, Jewell CM, Cidlowski JA (2001) Glucocorticoid- induced plasma membrane depolarization during thymocyte apoptosis: association with cell shrinkage and degradation of the Na(+)/K(+)-adenosine triphosphatase. Endocrinology 142(12):5059-5068
25. Matsumori A, Ono K, Nishio R, Igata H, Shioi T, Matsui S, Furukawa Y, Iwasaki A, Nose Y, Sasayama S (1991) Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation 96(5):1501-1506
26. Monte Neto RL, Sousa LM, Dias CS, Filho JM, Oliveira MR (2008) Yangambin cytotoxicity: a pharmacologically active lignan obtained from Ocotea duckei vattimo (Lauraceae). Z Naturforsch C J Biosci 63(9-10):681-686
27. Olej B, dos Santos NF, Leal L, Rumjanek VM (1998) Ouabain induces apoptosis on PHA-activated lymphocytes. Biosci Rep 18(1):1-7
28. Palatnik-de-Sousa CB, Day MJ (2011) One health: the global challenge of epidemic and endemic Leishmaniasis. Parasit Vectors 4:197. doi: 10.1186/1756-3305-4-197
29. Pires V, Harab RC, Olej B, Rumjanek VM (1997) Ouabain effects on activated lymphocytes: augmentation of CD25 expression on TPA-stimulated cells and of CD69 on PHA- and TPA-stimulated cells. Int J Immunopharmacol 19(3):143-148
30. Quastel MR, Kaplan JG (1968) Inhibition by ouabain of human lymphocyte transformation induced by phytohaemagglutinin in vitro. Nature 219(5150):198-200
31. 2+ entry. Life Sci 73(8):1037-1051
32. Rodrigues-Mascarenhas S, dos Santos NF, Rumjanek VM (2006) Synergistic effect between ouabain and glucocorticoids for the induction of thymic atrophy. Biosci Rep 26(2):159-169. doi: 10.1007/s10540-006-9012-1
33. Rodrigues-Mascarenhas S, Bloise FF, Moscat J, Rumjanek VM (2008) Ouabain inhibits p38 activation in thymocytes. Cell Biol Int 32(10):1323-1328. doi: 10.1016/j.cellbi.2008.07.012
34. Rodrigues-Mascarenhas S, Silva D, de Oliveira A, Amoedo ND, Affonso-Mitidieri OR, Rumjanek FD, Rumjanek VM (2009) Modulation of the immune system by ouabain. Acad Sci U S A 1153:153-163. doi: 10.1111/j.1749-6632.2008. 03969.x
35. Schoner W (2000) Ouabain, a new steroid hormone of adrenal gland and hypothalamus. Exp Clin Endocrinol Diabetes 108(7):449-454. doi: 10.1055/s-2000-8140
36. Schoner W, Bauer N, Müller-Ehmsen J, Krämer U, Hambarchian N, Schwinger R, Moeller H, Kost H, Weitkamp C, Schweitzer T, Kirch U, Neu H, GrÜnbaum EG (2003) Ouabain as a mammalian hormone. Acad Sci U S A 986:678-684
37. Szamel M, Resch K (1981) Inhibition of lymphocyte activation by ouabain. Interference with the early activation of membrane phospholipid metabolism. Biochim Biophys Acta 647(2):297-301
38. Valente RC, Nascimento CR, Araujo EG, Rumjanek VM (2009) mCD14 expression in human monocytes is downregulated by ouabain via transactivation of epithelial growth factor receptor and activation of p38 mitogen-activated protein kinase. Neuroimmunomodulation 16(4):228-236. doi: 10.1159/000212383
39. Vouldoukis I, Rougier S, Dugas B, Pino P, Mazier D, Woehrle F (2006) Canine visceral Leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate. Vet Parasitol 135(2):137-146. doi: 10.1016/j.vetpar.2005.09.003
40. Yang Q, Huang W, Jozwik C, Lin Y, Glasman M, Caohuy H, Srivastava M, Esposito D, Gillette W, Hartley J, Pollard HB (2005) Cardiac glycoides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. PNAS 102(27):9631-9636. doi: 10.1073/pnas.0504097102